MicroRNA: A signature for cancer progression

被引:242
作者
Hussen, Bashdar Mahmud [1 ]
Hidayat, Hazha Jamal [2 ]
Salihi, Abbas [3 ,4 ]
Sabir, Dana K. [5 ]
Taheri, Mohammad [6 ]
Ghafouri-Fard, Soudeh [7 ]
机构
[1] Hawler Med Univ, Dept Pharmacognosy, Coll Pharm, Erbil, Kurdistan Regio, Iraq
[2] Salahaddin Univ Erbil, Dept Biol, Coll Educ, Erbil, Kurdistan Regio, Iraq
[3] Salahaddin Univ Erbil, Dept Biol, Coll Sci, Erbil, Kurdistan Regio, Iraq
[4] Tishk Int Univ, Dept Med Anal, Fac Sci, Erbil, Iraq
[5] Charmo Univ, Dept Med Lab Sci, Chamchamal, Kurdistan Regio, Iraq
[6] Shahid Beheshti Univ Med Sci, Urol & Nephrol Res Ctr, Tehran, Iran
[7] Shahid Beheshti Univ Med Sci, Dept Med Genet, Tehran, Iran
关键词
MiRNA; Expression; Cancer; EPITHELIAL OVARIAN-CANCER; SUPPRESSOR MIRNA GENES; OPEN READING FRAME; TUMOR-SUPPRESSOR; BREAST-CANCER; DNA METHYLATION; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; GASTRIC-CANCER; HISTONE DEACETYLASES;
D O I
10.1016/j.biopha.2021.111528
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
MicroRNAs (miRNAs) are a group of small non-coding RNAs that post-transcriptionally control expression of genes by targeting mRNAs. miRNA alterations partake in the establishment and progression of different types of human cancer. Consequently, expression profiling of miRNA in human cancers has correlations with cancer detection, staging, progression, and response to therapies. Particularly, amplification, deletion, abnormal pattern of epigenetic factors and the transcriptional factors that mediate regulation of primary miRNA frequently change the landscape of miRNA expression in cancer. Indeed, changes in the quantity and quality of miRNAs are associated with the initiation of cancer, its progression and metastasis. Additionally, miRNA profiling has been used to categorize genes that can affect oncogenic pathways in cancer. Here, we discuss several circulating miRNA signatures, their expression profiles in different types of cancer and their impacts on cellular processes.
引用
收藏
页数:11
相关论文
共 210 条
  • [1] Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF--driven progression of pancreatic cancer
    Abukiwan, Alia
    Nwaeburu, Clifford C.
    Bauer, Nathalie
    Zhao, Zhefu
    Liu, Li
    Gladkich, Jury
    Gross, Wolfgang
    Benner, Axel
    Strobel, Oliver
    Fellenberg, Joerg
    Herr, Ingrid
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (01) : 53 - 64
  • [2] Emerging role of microRNAs in the pathogenesis of amyotrophic lateral sclerosis
    Akbari Dilmaghani, Nader
    Hussen, Bashdar Mahmud
    Nateghinia, Saeedeh
    Taheri, Mohammad
    Ghafouri-Fard, Soudeh
    [J]. METABOLIC BRAIN DISEASE, 2021, 36 (05) : 737 - 749
  • [3] Modelling urban growth evolution and land-use changes using GIS based cellular automata and SLEUTH models: the case of Sana'a metropolitan city, Yemen
    Al-shalabi, Mohamed
    Billa, Lawal
    Pradhan, Biswajeet
    Mansor, Shattri
    Al-Sharif, Abubakr A. A.
    [J]. ENVIRONMENTAL EARTH SCIENCES, 2013, 70 (01) : 425 - 437
  • [4] Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer
    Alpini, Gianfranco
    Glaser, Shannon S.
    Zhang, Jing-Ping
    Francis, Heather
    Han, Yuyan
    Gong, Jiao
    Stokes, Allison
    Francis, Taylor
    Hughart, Nathan
    Hubble, Levi
    Zhuang, Shi-Mei
    Meng, Fanyin
    [J]. JOURNAL OF HEPATOLOGY, 2011, 55 (06) : 1339 - 1345
  • [5] hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma
    Anwar, Sumadi Lukman
    Krech, Till
    Hasemeier, Britta
    Schipper, Elisa
    Schweitzer, Nora
    Vogel, Arndt
    Kreipe, Hans
    Buurman, Reena
    Skawran, Britta
    Lehmann, Ulrich
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (09) : 1568 - 1575
  • [6] miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
    Aqeilan, R. I.
    Calin, G. A.
    Croce, C. M.
    [J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (02) : 215 - 220
  • [7] Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets
    Arif, K. M. Taufiqul
    Elliott, Esther K.
    Haupt, Larisa M.
    Griffiths, Lyn R.
    [J]. CANCERS, 2020, 12 (10) : 1 - 26
  • [8] Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
    Babar, Imran A.
    Cheng, Christopher J.
    Booth, Carmen J.
    Liang, Xianping
    Weidhaas, Joanne B.
    Saltzman, W. Mark
    Slack, Frank J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (26) : E1695 - E1704
  • [9] Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation
    Baldari, Silvia
    Di Rocco, Giuliana
    Magenta, Alessandra
    Picozza, Mario
    Toietta, Gabriele
    [J]. CELLS, 2019, 8 (12)
  • [10] Regulation of chromatin by histone modifications
    Bannister, Andrew J.
    Kouzarides, Tony
    [J]. CELL RESEARCH, 2011, 21 (03) : 381 - 395